Epix Medical, Mallinckrodt, Pfizer deal

Pfizer will fund a Phase II trial to assess the efficacy of EPIX's AngioMark MRI contrast agent in diagnosing female sexual arousal dysfunction. The product is under joint development by EPIX and Mal...